(LCN) Gene Family, Including Evidence the Mouse Mup Cluster Is Result of an "Evolutionary Bloom"
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Analysis of Gene Expression Data for Gene Ontology
ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins. -
TESIS DOCTORAL: Lazarillo And
FACULTAD DE MEDICINA DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR Y FISIOLOGÍA TESIS DOCTORAL: Lazarillo and related Lipocalins: ligands and functions Presentada por MARIO RUIZ GARCIA para optar al grado de Doctor por la Universidad de Valladolid Dirigida por: Dra. María Dolores Ganfornina Álvarez Dr. Diego Sánchez Romero Impreso 2T AUTORIZACIÓN DEL DIRECTOR DE TESIS (Art. 2.1. c de la Normativa para la presentación y defensa de la Tesis Doctoral en la UVa) D. Diego Sánchez Romero, con D.N.I. nº29759524P, profesor del departamento de Bioquímica y Biología Molecular y Fisiología, y Dª. María Dolores Ganfornina Álvarez, con D.N.I. nº28873307G, profesora del departamento de Bioquímica y Biología Molecular y Fisiología, como Directores de la Tesis Doctoral titulada “Lazarillo and related Lipocalins: ligands and functions”, presentada por D. Mario Ruiz Garcia, alumno del programa de Investigación Biomédica impartido por el departamento de Bioquímica y Biología Molecular y Fisiología: Autorizan la presentación de la misma, considerando que el candidato ha superado el nivel de formación necesario para aspirar al Título de Doctor con Mención Internacional por la Universidad de Valladolid, mediante la realización de un proyecto de investigación original en el que su contribución abarca desde el diseño de las preguntas científicas y el diseño y ejecución de los experimentos, hasta la presentación en diversos formatos (escritura de trabajos para publicación y presentaciones en congresos) de los resultados para su difusión a la comunidad científica. Valladolid, 28 de Febrero de 2013 La Directora de la Tesis, El Director de la Tesis, Fdo.: María Dolores Ganfornina Álvarez Fdo.: Diego Sánchez Romero INDEX 1. -
Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]
University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed. -
The Acute-Phase Protein Orosomucoid Regulates Food Intake and Energy Homeostasis Via Leptin Receptor Signaling Pathway
1630 Diabetes Volume 65, June 2016 Yang Sun,1 Yili Yang,2 Zhen Qin,1 Jinya Cai,3 Xiuming Guo,1 Yun Tang,3 Jingjing Wan,1 Ding-Feng Su,1 and Xia Liu1 The Acute-Phase Protein Orosomucoid Regulates Food Intake and Energy Homeostasis via Leptin Receptor Signaling Pathway Diabetes 2016;65:1630–1641 | DOI: 10.2337/db15-1193 The acute-phase protein orosomucoid (ORM) exhibits a intake and energy expenditure. Energy homeostasis in the variety of activities in vitro and in vivo, notably modulation body is maintained by the integrated actions of multiple of immunity and transportation of drugs. We found in this factors (1,2), including adipose hormones (such as leptin study that mice lacking ORM1 displayed aberrant energy and adiponectin), gastrointestinal hormones (such as in- homeostasis characterized by increased body weight and sulin, ghrelin, and cholecystokinin), and nutrient-related fat mass. Further investigation found that ORM, predom- signals (such as free fatty acids). In addition to acting on fi inantly ORM1, is signi cantly elevated in sera, liver, and peripheral tissues, these actions can also influence central – adipose tissues from the mice with high-fat diet (HFD) circuits in the hypothalamus, brainstem, and limbic system db/db induced obesity and mice that develop obesity to modulate food intake and energy expenditure (1,3). spontaneously due to mutation in the leptin receptor Notably, the adipose tissue–produced leptin is a major (LepR). Intravenous or intraperitoneal administration of regulator of fat, and the level of leptin in circulation is exogenous ORM decreased food intake in C57BL/6, HFD, proportional to body fat (4) and is a reflection of long- and leptin-deficient ob/ob mice, which was absent in db/db OBESITY STUDIES fi term nutrition status as well as acute energy balance. -
Alpha 1 Acid Glycoprotein (ORM1) (NM 000607) Human Untagged Clone Product Data
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for SC119782 Alpha 1 Acid Glycoprotein (ORM1) (NM_000607) Human Untagged Clone Product data: Product Type: Expression Plasmids Product Name: Alpha 1 Acid Glycoprotein (ORM1) (NM_000607) Human Untagged Clone Tag: Tag Free Symbol: ORM1 Synonyms: AGP-A; AGP1; HEL-S-153w; ORM Vector: pCMV6-XL4 E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: None Fully Sequenced ORF: >OriGene ORF within SC119782 sequence for NM_000607 edited (data generated by NextGen Sequencing) ATGGCGCTGTCCTGGGTTCTTACAGTCCTGAGCCTCCTACCTCTGCTGGAAGCCCAGATC CCATTGTGTGCCAACCTAGTACCGGTGCCCATCACCAACGCCACCCTGGACCAGATCACT GGCAAGTGGTTTTATATCGCATCGGCCTTTCGAAACGAGGAGTACAATAAGTCGGTTCAG GAGATCCAAGCAACCTTCTTTTACTTCACCCCCAACAAGACAGAGGACACGATCTTTCTC AGAGAGTACCAGACCCGACAGGACCAGTGCATCTATAACACCACCTACCTGAATGTCCAG CGGGAAAATGGGACCATCTCCAGATACGTGGGAGGCCAAGAGCATTTCGCTCACTTGCTG ATCCTCAGGGACACCAAGACCTACATGCTTGCTTTTGACGTGAACGATGAGAAGAACTGG GGGCTGTCTGTCTATGCTGACAAGCCAGAGACGACCAAGGAGCAACTGGGAGAGTTCTAC GAAGCTCTCGACTGCTTGCGCATTCCCAAGTCAGATGTCGTGTACACCGATTGGAAAAAG GATAAGTGTGAGCCACTGGAGAAGCAGCACGAGAAGGAGAGGAAACAGGAGGAGGGGGAA TCCTAG Clone variation with respect to NM_000607.2 113 g=>a This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 Alpha 1 Acid Glycoprotein -
ORM1 Antibody / Orosomucoid 1 (R32415)
ORM1 Antibody / Orosomucoid 1 (R32415) Catalog No. Formulation Size R32415 0.5mg/ml if reconstituted with 0.2ml sterile DI water 100 ug Bulk quote request Availability 1-3 business days Species Reactivity Human, Mouse, Rat Format Antigen affinity purified Clonality Polyclonal (rabbit origin) Isotype Rabbit IgG Purity Antigen affinity Buffer Lyophilized from 1X PBS with 2.5% BSA and 0.025% sodium azide UniProt P02763 Localization Cytoplasmic Applications Western blot : 0.1-0.5ug/ml IHC (FFPE) : 0.5-1ug/ml ELISA : 0.1-0.5ug/ml (human protein tested); request BSA-free format for coating Limitations This ORM1 antibody is available for research use only. Western blot testing of 1) rat liver, 2) mouse liver and 3) human PANC lysate with ORM1 antibody. Expected molecular weight: 24/41-60 kDa (unmodified/glycosylated). IHC testing of FFPE human intestinal cancer tissue with ORM1 antibody. HIER: Boil the paraffin sections in pH 6, 10mM citrate buffer for 20 minutes and allow to cool prior to testing. Description Alpha-1-acid glycoprotein 1 is a protein that in humans is encoded by the ORM1 gene. The structural gene for orosomucoid (ORM1) is assigned to the end of the long arm of chromosome 9 by demonstration of linkage to ABO and AK1. This gene encodes a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined; however, it may be involved in aspects of immunosuppression. Application Notes Optimal dilution of the ORM1 antibody should be determined by the researcher. -
Recombinant Human Lipocalin-1 Protein Catalog Number: ATGP2816
Recombinant human Lipocalin-1 protein Catalog Number: ATGP2816 PRODUCT INPORMATION Expression system E.coli Domain 19-176aa UniProt No. P31025 NCBI Accession No. NP_001239546 Alternative Names Lipocalin-1, PMFA, TLC, TP, VEGP PRODUCT SPECIFICATION Molecular Weight 20.1 kDa (183aa) confirmed by MALDI-TOF Concentration 1mg/ml (determined by Bradford assay) Formulation Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol, 1mM DTT Purity > 90% by SDS-PAGE Tag His-Tag Application SDS-PAGE Storage Condition Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles. BACKGROUND Description LCN1 is a member of the lipocalin family of small secretory proteins. Lipocalins are extracellular transport proteins that bind to a variety of hydrophobic ligands. This protein is the primary lipid binding protein in tears and is overproduced in response to multiple stimuli including infection and stress. It may be a marker for chromosome aneuploidy as well as an autoantigen in Sjogren's syndrome. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and two pseudogenes of this gene are also located on the long arm of chromosome 9. Recombinant human LCN1 protein, fused to His-tag at N- 1 Recombinant human Lipocalin-1 protein Catalog Number: ATGP2816 terminus, was expressed in E. coli and purified by using conventional chromatography techniques. Amino acid Sequence MGSSHHHHHH SSGLVPRGSH MGSHMHHLLA SDEEIQDVSG TWYLKAMTVD REFPEMNLES VTPMTLTTLE GGNLEAKVTM LISGRCQEVK AVLEKTDEPG KYTADGGKHV AYIIRSHVKD HYIFYCEGEL HGKPVRGVKL VGRDPKNNLE ALEDFEKAAG ARGLSTESIL IPRQSETCSP GSD General References Dartt DA. (2011), Ocul Surf. -
"The Genecards Suite: from Gene Data Mining to Disease Genome Sequence Analyses". In: Current Protocols in Bioinformat
The GeneCards Suite: From Gene Data UNIT 1.30 Mining to Disease Genome Sequence Analyses Gil Stelzer,1,5 Naomi Rosen,1,5 Inbar Plaschkes,1,2 Shahar Zimmerman,1 Michal Twik,1 Simon Fishilevich,1 Tsippi Iny Stein,1 Ron Nudel,1 Iris Lieder,2 Yaron Mazor,2 Sergey Kaplan,2 Dvir Dahary,2,4 David Warshawsky,3 Yaron Guan-Golan,3 Asher Kohn,3 Noa Rappaport,1 Marilyn Safran,1 and Doron Lancet1,6 1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel 2LifeMap Sciences Ltd., Tel Aviv, Israel 3LifeMap Sciences Inc., Marshfield, Massachusetts 4Toldot Genetics Ltd., Hod Hasharon, Israel 5These authors contributed equally to the paper 6Corresponding author GeneCards, the human gene compendium, enables researchers to effectively navigate and inter-relate the wide universe of human genes, diseases, variants, proteins, cells, and biological pathways. Our recently launched Version 4 has a revamped infrastructure facilitating faster data updates, better-targeted data queries, and friendlier user experience. It also provides a stronger foundation for the GeneCards suite of companion databases and analysis tools. Improved data unification includes gene-disease links via MalaCards and merged biological pathways via PathCards, as well as drug information and proteome expression. VarElect, another suite member, is a phenotype prioritizer for next-generation sequencing, leveraging the GeneCards and MalaCards knowledgebase. It au- tomatically infers direct and indirect scored associations between hundreds or even thousands of variant-containing genes and disease phenotype terms. Var- Elect’s capabilities, either independently or within TGex, our comprehensive variant analysis pipeline, help prepare for the challenge of clinical projects that involve thousands of exome/genome NGS analyses. -
Anti-ORM1 / Alpha 1 Acid Glycoprotein Antibody (ARG41542)
Product datasheet [email protected] ARG41542 Package: 100 μl anti-ORM1 / alpha 1 Acid Glycoprotein antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes ORM1 / alpha 1 Acid Glycoprotein Tested Reactivity Hu Tested Application IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name ORM1 / alpha 1 Acid Glycoprotein Antigen Species Human Immunogen Synthetic peptide of Human ORM1 / alpha 1 Acid Glycoprotein. Conjugation Un-conjugated Alternate Names AGP1; HEL-S-153w; AGP 1; AGP-A; OMD 1; ORM; Alpha-1-acid glycoprotein 1; Orosomucoid-1 Application Instructions Application table Application Dilution IHC-P 1:50 - 1:200 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Human testis Calculated Mw 24 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.4), 150 mM NaCl, 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Gene Symbol ORM1 Gene Full Name orosomucoid 1 Background This gene encodes a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. -
Rare Variants and Loci for Age-Related Macular Degeneration in The
Human Genetics (2019) 138:1171–1182 https://doi.org/10.1007/s00439-019-02050-4 ORIGINAL INVESTIGATION Rare variants and loci for age‑related macular degeneration in the Ohio and Indiana Amish Andrea R. Waksmunski1,2,3 · Robert P. Igo Jr.3 · Yeunjoo E. Song3 · Jessica N. Cooke Bailey2,3 · Renee Laux3 · Denise Fuzzell3 · Sarada Fuzzell3 · Larry D. Adams4 · Laura Caywood4 · Michael Prough4 · Dwight Stambolian5 · William K. Scott4 · Margaret A. Pericak‑Vance4 · Jonathan L. Haines1,2,3 Received: 27 April 2019 / Accepted: 21 July 2019 / Published online: 31 July 2019 © The Author(s) 2019 Abstract Age-related macular degeneration (AMD) is a leading cause of blindness in the world. While dozens of independent genomic variants are associated with AMD, about one-third of AMD heritability is still unexplained. To identify novel variants and loci for AMD, we analyzed Illumina HumanExome chip data from 87 Amish individuals with early or late AMD, 79 unafected Amish individuals, and 15 related Amish individuals with unknown AMD afection status. We retained 37,428 polymorphic autosomal variants across 175 samples for association and linkage analyses. After correcting for multiple testing (n = 37,428), we identifed four variants signifcantly associated with AMD: rs200437673 (LCN9, p = 1.50 × 10−11), rs151214675 (RTEL1, p = 3.18 × 10−8), rs140250387 (DLGAP1, p = 4.49 × 10−7), and rs115333865 (CGRRF1, p = 1.05 × 10−6). These variants have not been previously associated with AMD and are not in linkage disequilibrium with the 52 known AMD-associated variants reported by the International AMD Genomics Consortium based on physical distance. Genome-wide signifcant linkage peaks were observed on chromosomes 8q21.11–q21.13 (maximum recessive HLOD = 4.03) and 18q21.2–21.32 (maximum dominant HLOD = 3.87; maximum recessive HLOD = 4.27). -
Multiple Roles of Secretory Lipocalins (Mup, Obp) in Mice
Folia Zool. – 58 (Suppl. 1): 29–40 (2009) Multiple roles of secretory lipocalins (Mup, Obp) in mice Romana STOPKOVÁ1, Denisa HLADOVCOVÁ1, Juraj KOKAVEC2, Daniel VYORAL2 and Pavel STOPKA1,3* 1 Department of Zoology, Faculty of Science, Charles University, Prague, Viničná 7, Prague, 128 44, Czech Republic; e-mail: [email protected] 2 Pathological Physiology and Center of Experimental Hematology, First Faculty of Medicine, Charles University in Prague, Czech Republic 3 Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Rumburska 89, 277 21 Libechov, Czech Republic Received 1 December 2008; Accepted 1 April 2009 Abstract. Many biological processes involve globular transport proteins belonging to a family called lipocalins. The prominent feature in lipocalin structure is their specific tertiary conformation forming eight-stranded beta barrel with capacity to bind various ligands inside. The importance of lipocalins is evident from the list of vital substances (hydrophobic ligands including vitamin A, steroids, bilins, lipids, pheromones etc.) that these proteins transport and from their high expression levels in various tissues. Among wide spectrum of lipocalins, Major Urinary Proteins (Mup) and Odorant Binding Proteins (Obp) are well known for their capacity to bind and carry odorants / pheromones and have been studied to detail in various mammalian models including mice, rats, and hamsters. However, many lipocalins (also including Mups) have previously been described with respect to their protective function in mammalian organism where they transport potentially harmful molecules to a degradation site (e.g. lysozomes) or straight out of the body. As most of lipocalins share similar tertiary structure, their potential role in both transport and excretion processes may be additive or complementary. -
Signature in Peripheral Blood Neutrophils Periodontitis
Periodontitis Associates with a Type 1 IFN Signature in Peripheral Blood Neutrophils Helen J. Wright, John B. Matthews, Iain L. C. Chapple, Nic Ling-Mountford and Paul R. Cooper This information is current as of September 23, 2021. J Immunol 2008; 181:5775-5784; ; doi: 10.4049/jimmunol.181.8.5775 http://www.jimmunol.org/content/181/8/5775 Downloaded from References This article cites 72 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/181/8/5775.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 23, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Periodontitis Associates with a Type 1 IFN Signature in Peripheral Blood Neutrophils1 Helen J. Wright, John B. Matthews, Iain L. C. Chapple, Nic Ling-Mountford, and Paul R. Cooper2 Peripheral blood neutrophils from periodontitis patients exhibit a hyperreactive and hyperactive phenotype (collectively termed hyperresponsivity) in terms of production of reactive oxygen species (ROS).